This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

In a high-profile showdown Tuesday with Sen. Bernie Sanders’ Senate health committee, Novo Nordisk CEO Lars Fruergaard ...

Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

As the Senate Committee on Health, Education, Labor and Pensions (HELP) gears up for a hearing tomorrow titled “Why Is Novo ...

Hearing on weight loss drug prices will feature CEO of Novo Nordisk and comes after threats to subpoena company executives.

Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are ...

Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a ...

As a possible indication that the hearing, which starts at 10a ET, could get contentious, it has the title, "Why is Novo ...

Novo Nordisk CEO Lars Jergensen testified on the company's pricing for its diabetes and weight loss drugs, Ozempic and Wegovy, respectively. Public affairs events, congressional hearings, speeches, ...

Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the ...

Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of ...